Financial Performance: Revenue growth, profitability (net profit margin), and earnings per share (EPS) directly impact investor confidence.

Industry Trends: Overall growth and performance of the pharmaceutical sector and specific segments (like generics, APIs) influence investor sentiment.

Regulatory Environment: Changes in drug pricing regulations, patent laws, and approvals by regulatory bodies like DCGI affect future revenue potential.

Competition: Emergence of new players or aggressive pricing strategies by existing competitors can affect market share and profitability.

Macroeconomic Factors: Inflation, interest rates, and exchange rates impact operational costs and overall investor risk appetite.

Company-Specific News: Announcements about new drug launches, acquisitions, collaborations, or setbacks in clinical trials can cause significant price fluctuations.

Investor Sentiment: General market optimism or pessimism and news coverage about the company affect demand for its shares.